Back

Developing an Antiviral Peptides Predictor with Generative Adversarial Network Data Augmentation

Lin, T.-T.; Sun, Y.-Y.; Cheng, W.-C.; Lu, I.-H.; Chen, S.-H.; Lin, C.-Y.

2021-11-30 microbiology
10.1101/2021.11.29.470292 bioRxiv
Show abstract

MotivationNew antiviral drugs are urgently needed because of emerging viral pathogens increasing severity and drug resistance. Antiviral peptides (AVPs) have multiple antiviral properties and are appealing candidates for antiviral drug development. We developed a sequence-based binary classifier to identify whether an unknown short peptide has AVP activity. We collected AVP sequence data from six existing databases. We used a generative adversarial network to augment the number of AVPs in the positive training dataset and allow our deep convolutional neural network model to train on more data. ResultsOur classifier achieved outstanding performance on the testing dataset compared with other state-of-the-art classifiers. We deployed our trained classifier on a user-friendly web server. Availability and implementationAI4AVP is freely accessible at http://axp.iis.sinica.edu.tw/AI4AVP/ Contactcylin@iis.sinica.edu.tw Supplementary informationSupplementary data is also available.

Matching journals

The top 9 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.